학술논문

Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer
Document Type
Article
Source
In: Bioorganic and Medicinal Chemistry Letters. (Bioorganic and Medicinal Chemistry Letters, 15 January 2023, 80)
Subject
Language
English
ISSN
14643405
0960894X